C8A

C8A encodes the alpha subunit of complement component C8, a terminal complement protein that participates in membrane attack complex (MAC) formation as part of the alpha-gamma/beta heterotrimer (PMID:468996, PMID:11733582). The C8A and C8B loci, encoding the alpha-gamma and beta subunits respectively, are closely linked (<2.5 kb apart) on chromosome 1p in 5'-alpha-beta-3' orientation, while the gamma subunit gene C8G lies on chromosome 9q; C8A and C8B are separately mutable structural loci, each governing extensive protein polymorphism with codominant inheritance (PMID:2613233, PMID:468996, PMID:8098723). The two common C8A protein alleles differ by a single Gln-to-Lys substitution arising from a point mutation in exon 3 (PMID:7649542), and C8A shares exon/intron architecture with the homologous terminal complement genes C6, C7, C8B, and C9 (PMID:7730625). C8A is synthesized primarily in the liver, where its transcription requires the hepatic nuclear factors HNF1alpha and HNF4alpha, the latter coordinately regulating multiple MAC-forming complement genes (PMID:11733582, PMID:39285151), and its expression is induced by IL-6 as part of the acute-phase response (PMID:7710765). Loss of the alpha-gamma subunit secondarily depletes the beta subunit, consistent with obligate assembly of the subunits into a stable heterotrimer (PMID:11733582). C8 alpha-gamma deficiency is a defined genetic disorder caused by C8A mutations, including an intron 6 G-to-A change that creates a preferentially used 3' splice site, producing a frameshift and premature stop codon and accounting for most C8 alpha-gamma deficiency in African Americans (PMID:32769119).

1. 1979 High

   Established that C8 structural variation is governed by two distinct linked loci with codominant inheritance, defining C8A as a genetic locus controlling the alpha-gamma subunit and framing C8 deficiency as a null allele.

   Evidence Isoelectric focusing with hemolytic assay and family segregation analysis

   PMID:468996

   Open questions at the time

   • Did not define the molecular gene structure or the causal mutations
   • Subunit assembly mechanism not addressed
2. 1989 High

   Resolved the physical genomic organization of the C8 genes, showing C8A and C8B are tightly linked on chromosome 1p while C8G is unlinked on 9q, with alpha-gamma-to-beta linkage determined by the alpha subunit.

   Evidence Somatic cell hybrid analysis with 5'/3'-specific cDNA probes and genomic Southern blot

   PMID:2613233

   Open questions at the time

   • Did not address how the dispersed subunits assemble into a functional heterotrimer
   • Regulatory elements not mapped
3. 1993 High

   Demonstrated that C8A and C8B are independently mutable loci by showing C8 beta deficiency arises from a C8B exon 9 nonsense mutation segregating independently of C8A allotypes.

   Evidence Exon-specific PCR, direct sequencing, allele-specific PCR, and RFLP family typing

   PMID:8098723

   Open questions at the time

   • Concerns C8B rather than C8A directly
   • C8A-specific deficiency mutations not yet defined
4. 1995 High

   Characterized the molecular basis of common C8A allotype polymorphism and placed C8A within the conserved terminal-complement gene family architecture.

   Evidence Exon-specific PCR and direct sequencing cross-validated against protein typing; comparative genomic exon-structure analysis across C6/C7/C8A/C8B/C9

   PMID:7649542 PMID:7730625

   Open questions at the time

   • Functional consequence of the Gln/Lys substitution not assessed
   • Domain-function correspondence inferred by homology
5. 1995 Medium

   Showed C8A is a hepatic acute-phase-responsive gene, linking its expression to inflammatory signaling.

   Evidence Immunoprecipitation of biosynthetically labeled subunits from IL-6-treated HepG2 cells plus transcript comparison

   PMID:7710765

   Open questions at the time

   • Transcriptional regulators mediating the IL-6 response not identified
   • Single cell-line system
6. 2001 High

   Identified HNF1alpha as a required in vivo transcriptional driver of C8A and revealed that loss of alpha-gamma secondarily depletes the beta subunit, implying obligate subunit assembly.

   Evidence HNF1alpha-knockout mice with reconstitution hemolytic assays using selective complement-deficient sera and liver mRNA analysis

   PMID:11733582

   Open questions at the time

   • Direct HNF1alpha binding to the C8A promoter not mapped
   • Molecular basis of secondary beta depletion not resolved
7. 2020 High

   Defined the predominant molecular cause of C8 alpha-gamma deficiency in African Americans as an intronic splice-site-creating mutation, mechanistically validating aberrant splicing.

   Evidence Genomic sequencing, in vitro splicing assay of wild-type vs mutant intron 6/exon 7 substrates, and patient mRNA analysis

   PMID:32769119

   Open questions at the time

   • Population frequency and penetrance not quantified here
   • Protein-level fate of the truncated product not characterized
8. 2024 High

   Established HNF4alpha as a coordinate transcriptional regulator of MAC-forming complement genes, extending the hepatic regulatory control of C8A beyond HNF1alpha.

   Evidence Liver-specific Hnf4a-knockout mice, siRNA knockdown and forced expression in hepatocytes, and transactivation assays with binding-site mutagenesis

   PMID:39285151

   Open questions at the time

   • Direct HNF4alpha binding to the C8A promoter shown only for C8G/C9, not C8A specifically
   • Interplay between HNF1alpha and HNF4alpha not dissected
9. 2021 Medium

   Provided systems-level evidence that C8A loss perturbs the plasma proteome and humoral defense network, characterizing downstream consequences of deficiency.

   Evidence Targeted mass spectrometry proteomics of C8a-knockout vs wild-type mouse plasma

   PMID:34050187

   Open questions at the time

   • Mechanistic link between C8A loss and altered Ig alpha chain levels unresolved
   • Single lab and species

• How the C8 alpha subunit physically engages CD59 and assembles into the MAC at residue-level resolution in humans remains experimentally unestablished.
• No experimental validation of the proposed CD59-recognition site or assembly residues in human C8A
• No structural model of the human heterotrimer in the corpus